About US
   
ProfoundBio is a clinical stage biotherapeutics company focused on the development of novel antibody-based therapeutics with curative potential for patients with cancer.

Built on innovative technology platforms, ProfoundBio has developed a pipeline consisting of multiple candidates that are currently in discovery, preclinical development, and clinical stage targeting a broad range of tumors. 
Our Mission
Aiming to help patients with cancer through discovery and development of novel targeted therapy with curative potential.

We are focused on discovering and advancing novel antibody-based therapeutic agents with diverse mechanisms of action in treating patients with a broad range of cancers.

Our team of experienced scientists and clinicians take a fresh look at how  best to eradicate cancer and a creative approach to drug discovery and development in rapidly bringing novel therapy to patients.